Company: GEHC
Filing Date: 2025-04-30
Form Type: 10-Q
Source: 0001932393-25-000014
Chunk: 37

Company: GE HealthCare Technologies Inc.
Filing Date: 2025-04-30
Form: 10-Q
Item: Item 8
Chunk 37
---
)—AVS Organic revenue*    $1,258$1,2273%PCS revenues    $753$7471%Less: Acquisitions(1)    ——Less: Dispositions(2)    ——Less: Foreign currency exchange    (7)—PCS Organic revenue*    $760$7472%PDx revenues    $632$5996%Less: Acquisitions(1)    ——Less: Dispositions(2)    ——Less: Foreign currency exchange    (14)—PDx Organic revenue*    $646$5998%Other revenues    $13$15(11)%Less: Acquisitions(1)    ——Less: Dispositions(2)    ——Less: Foreign currency exchange    ——Other Organic revenue*    $13$15(10)%Total revenues    $4,777$4,6503%Less: Acquisitions(1)    14—Less: Dispositions(2)    ——Less: Foreign currency exchange    (78)—Organic revenue*    $4,842$4,6504%

(1)Represents revenues attributable to acquisitions from the date the Company completed the transaction through the end of four quarters following the transaction.(2)Represents revenues attributable to dispositions for the four quarters preceding the disposition date.

____________________*Non-GAAP Financial Measure

33

Table of Contents                 

Adjusted EBIT*For the three months ended March 3120252024 % changeNet income attributable to GE HealthCare    $564$37451%Add: Interest and other financial charges – net    110122Add: Non-operating benefit (income) costs    (74)(102)Less: Benefit (provision) for income taxes    (104)(124)Less: Net (income) loss attributable to noncontrolling interests     (24)(14)EBIT*    $728$53137%Add: Restructuring costs(1)    2240Add: Acquisition and disposition-related charges (benefits)(2)    8—Add: Spin-Off and separation costs(3)    2460Add: (Gain) loss on business and asset dispositions(4)    (10)—Add: Amortization of acquisition-related intangible assets    3531Add: Investment revaluation (gain) loss(5)    (92)20Adjusted